Inspire Medical Systems (INSP) Cash & Current Investments (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Cash & Current Investments data on file, last reported at $283.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 23.12% year-over-year to $283.8 million; the trailing twelve-month figure through Mar 2026 stood at $283.8 million (down 23.12% YoY), and the FY2025 full-year result was $308.3 million, down 30.81% from the prior year.
• Cash & Current Investments declined to $283.8 million in Q1 2026, from $308.3 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $467.1 million in Q2 2023 to a low of $196.3 million in Q2 2022.
• A 5-year average of $379.1 million and a median of $427.5 million in 2022 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments soared 137.9% in 2023 and sank 31.56% in 2025, its largest moves.
• Tracing INSP's Cash & Current Investments over 5 years: stood at $451.4 million in 2022, then rose by 1.99% to $460.4 million in 2023, then retreated by 3.22% to $445.5 million in 2024, then tumbled by 30.81% to $308.3 million in 2025, then retreated by 7.93% to $283.8 million in 2026.
• Business Quant data shows INSP's Cash & Current Investments at $283.8 million in Q1 2026, $308.3 million in Q4 2025, and $322.6 million in Q3 2025.